TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
In a cluster randomized trial, agenda-setting cards for adults with type 2 diabetes were linked to higher clinician satisfaction, but did not significantly improve care-fit scores or HbA1c after six months. Medication adherence and some medication adjustments were higher in the intervention group, though the findings do not establish that the cards improved overall clinical outcomes.
A cluster randomized trial found that conversation cards used during routine primary care visits made clinicians more likely to say they were satisfied with the visit, but did not significantly improve patients’ reported fit between diabetes treatment and daily life or their HbA1c levels after six months. The findings suggest that helping patients raise concerns may improve the discussion without, by itself, changing key patient outcomes.
The study tested a kit of 14 agenda-setting cards about living with diabetes and its treatment. Before a visit, patients could choose up to three topics they wanted to discuss. Clinicians were asked to review and respond to those cards first, then continue the appointment as usual. The intervention was designed to support a focused conversation, not to serve as a full diabetes self-management program.
At six months, mean scores on the Illness Intrusiveness Ratings Scale were 32.1 in the card group and 37.1 in the usual-care group. The scale ranges from 13 to 91, with higher scores indicating greater disruption of daily life. The researchers reported no significant difference between groups. Mean HbA1c was 8.8% versus 9.1%, respectively, also without a significant difference. Treatment burden and diabetes distress scores likewise did not differ significantly.
Clinician responses were more positive in the intervention group: 62.2% strongly agreed they were satisfied with how the visit went, compared with 19.1% in usual care. In addition, 59.5% strongly agreed they felt confident responding to patient concerns, versus 30.9%. Patient satisfaction was high in both groups and did not differ. The report also noted higher medication adherence, measured by proportion of days covered, in the intervention group (77.2% versus 64.6%) and more adjustments to existing medications (33.8% versus 23.2%). These findings do not change the report’s conclusion that the primary care-fit and HbA1c outcomes were not significantly improved.
Better Conversations, Same Main Outcomes
The findings address a practical question in diabetes care: can a short prompt help clinicians understand the pressures that shape a patient’s ability to follow treatment? The cards gave patients a structured way to identify priorities, and clinicians reported greater satisfaction and confidence. That may matter for the quality of routine visits, even though the trial did not show a significant improvement in the measured patient outcomes.
The results also distinguish identifying a barrier from having the capacity to address it. Patients may raise concerns about medication costs, food access, transport, work schedules, caregiving, side effects or distress. A brief appointment may not provide the services or time needed to resolve them. The accompanying commentary argued that responding to such priorities may require clinical and community support beyond the conversation itself.
For readers and health systems, the study is a reminder not to treat clinician satisfaction as proof of better disease control. The adherence and medication-adjustment results are encouraging signals reported by the study, but the principal outcomes described in the report did not show significant between-group benefits at six months.
diabetes medication adherence tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
A Brief Tool in Primary Care
The QBSafe trial randomized clinicians 1:1 to use the cards or provide usual primary care. It ran from February 2023 to July 2024 at a federally qualified health center in New Haven, Connecticut. Participating clinicians included physicians, nurse practitioners and physician assistants who prescribed medication for adults with type 2 diabetes.
Participants had elevated blood sugar at enrollment: baseline HbA1c was required to be above 8%, and the group mean was 10%. The average age was 56.2; 60.8% were women, 72.7% were Hispanic or Latino, and 61.5% reported Spanish as their primary language. The report said 91.3% had family incomes below 150% of the federal poverty level. The authors described the intervention as a pragmatic way to improve conversations about whether treatment fits patients’ lives, rather than an added self-management curriculum.
In a commentary accompanying the study, Megha K. Shah and Ambar Kulshreshtha of Emory University praised the approach for not increasing visit length, while cautioning that naming a problem does not itself supply the resources to solve it. The trial authors similarly said the tool may support person-centered conversations, while its effect on specific outcomes may be modest without further support for clinicians.
“The intervention “may serve as a low-burden, scalable tool for supporting person-centered conversations, even if their impact on specific outcomes may be modest without further supports or tools for clinicians to help them respond to patient concerns.””
— Kasia Lipska and colleagues, the trial authors
As an affiliate, we earn on qualifying purchases.
Limits of the Six-Month Findings
The reported results do not establish why clinician satisfaction increased while the measured care-fit and HbA1c outcomes did not significantly change. The source material does not provide enough detail to determine whether particular card topics led to follow-up services, or whether patients’ concerns were resolved after the visits. It also does not establish whether the adherence and medication-adjustment differences would produce longer-term clinical benefits.
The trial took place at one federally qualified health center and involved a patient group with substantial social and financial risks. Whether the results would be similar in other clinics, populations or health systems remains uncertain. The available report describes six-month outcomes; it does not provide evidence here about longer-term effects.
diabetes management patient engagement
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Building Support Beyond the Visit
The authors and commentators point toward pairing agenda-setting tools with ways for clinicians to act on what patients disclose. That could mean stronger links to clinical and community resources, although the supplied report does not identify a specific next intervention or confirm that one is planned.
Further research would need to test whether added support can turn more focused conversations into sustained changes in treatment fit, medication use or blood sugar control. For now, the trial supports a limited conclusion: the cards were associated with higher clinician satisfaction, while significant improvement in the reported care-fit and HbA1c outcomes was not shown at six months.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the diabetes conversation cards ask patients to do?
The kit contained 14 cards about life with diabetes and its treatment. Patients could choose up to three topics to prioritize before speaking with their clinician.
Did the cards lower HbA1c?
The trial report showed mean six-month HbA1c levels of 8.8% in the intervention group and 9.1% in usual care, but reported no significant difference between the groups.
What improved in the intervention group?
Clinicians were more likely to strongly agree that they were satisfied with the visit and confident responding to patient concerns. The report also found higher medication adherence and more adjustments to existing medications in the intervention group; these results do not establish an overall improvement in the main clinical outcomes.
Did the cards make appointments longer?
The accompanying commentary praised the intervention for not increasing encounter length. The source material does not provide visit-duration figures.
What does the study suggest is still needed?
The authors and commentators said clinicians may need additional clinical and community support to respond to priorities raised during visits. The report does not specify a particular support program or a confirmed next trial.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
